Prospective Multicenter Evaluation of Hepatocellular Carcinoma Surveillance under American Association for the Study of Liver Diseases Version 2023 Guidance
Radiology · 2026
DOI: 10.1148/radiol.252252 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Radiology, 2026. Verfasst von Mei-Qing Cheng und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, The First Affiliated Hospital of Sun Yat-Sen University, 58…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
American Association for the Study of Liver Diseases (AASLD) version 2023, which incorporates visualization score VIS-C, increasing α-fetoprotein level, and lesion growth, improved sensitivity and negative predictive value for hepatocellular carcinoma surveillance, outperforming US Liver Imaging Reporting System version 2017 and AASLD version 2018.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, The First Affiliated Hospital of Sun Yat-Sen University, 58 Zhongshan Rd 2, Guangzhou 510080, China.
- Department of Medical Ultrasonics, Guizhou Hospital, The First Affiliated Hospital of Sun Yat-Sen University, Guizhou, China.
- Department of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
- Department of Traditional Chinese Medicine, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
- Department of Medical Ultrasonics, Sanshui District People's Hospital, Foshan, China.
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
ORCID-Profile: Mei-Qing Cheng, Hang-Tong Hu, Shao-Hong Wu, Hui Huang, Ya-Dan Lin, Wen-Juan Tong, Xiao-Zhou Lu, Wei-Ping Ke, Rui-Fang Lu, Qian-Qian Xu, Xin-Xin Lin, Ming-De Lu, Hong Yang, Wei Wang, Li-Da Chen
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Cheng, M. Q., Hu, H. T., Wu, S. H., Huang, H., Lin, Y. D., Tong, W. J., Lu, X. Z., Ke, W. P., Lu, R. F., Xu, Q. Q., Wang, Y., Lin, X. X., Liu, Z. Z., Lu, Z. R., Lu, M. D., Yang, H., Wang, W., & Chen, L. D. (2026). Prospective Multicenter Evaluation of Hepatocellular Carcinoma Surveillance under American Association for the Study of Liver Diseases Version 2023 Guidance. Radiology. https://doi.org/10.1148/radiol.252252
Vancouver
Cheng MQ, Hu HT, Wu SH, Huang H, Lin YD, Tong WJ, et al. Prospective Multicenter Evaluation of Hepatocellular Carcinoma Surveillance under American Association for the Study of Liver Diseases Version 2023 Guidance. Radiology. 2026. doi:10.1148/radiol.252252
BibTeX
@article{Cheng2026,
author = {Cheng, Mei-Qing and Hu, Hang-Tong and Wu, Shao-Hong and Huang, Hui and Lin, Ya-Dan and Tong, Wen-Juan and Lu, Xiao-Zhou and Ke, Wei-Ping and Lu, Rui-Fang and Xu, Qian-Qian and Wang, Yu and Lin, Xin-Xin and Liu, Ze-Zhi and Lu, Zhi-Rong and Lu, Ming-De and Yang, Hong and Wang, Wei and Chen, Li-Da},
title = {Prospective Multicenter Evaluation of Hepatocellular Carcinoma Surveillance under American Association for the Study of Liver Diseases Version 2023 Guidance},
journal = {Radiology},
year = {2026},
doi = {10.1148/radiol.252252}
}
EUVIMED